Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
- USD | -.--% | -.--% | -.--% |
2021 | WCG Clinical : GIC-backed clinical trial firm WCG withdraws U.S. IPO plans | RE |
2021 | WCG Clinical : GIC-backed clinical trial firm WCG withdraws IPO plans | RE |
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Srivastava Sam
CEO | Chief Executive Officer | - | - |
Nicholas Slack
PSD | President | 41 | 01/12/01 |
Ian Neilson
CTO | Chief Tech/Sci/R&D Officer | - | 01/18/01 |
Lindsay McNair
CTO | Chief Tech/Sci/R&D Officer | - | - |
David Forster
CMP | Compliance Officer | - | - |
Lisa Calicchio
HRO | Human Resources Officer | - | - |
Marco Capasso
LAW | General Counsel | - | - |
General Counsel | 54 | 01/21/01 | |
Treasurer | 41 | 01/13/01 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
John Baumer
BRD | Director/Board Member | 56 | 01/19/01 |
Eugene Gorbach
BRD | Director/Board Member | 47 | 01/12/01 |
Director/Board Member | 66 | 01/12/01 | |
James Rothman
BRD | Director/Board Member | 74 | 01/12/01 |
Richard Pilnik
BRD | Director/Board Member | 67 | 01/21/01 |
Director/Board Member | - | 01/12/01 | |
Kavita Patel
BRD | Director/Board Member | 50 | 01/20/01 |
Director/Board Member | 48 | 01/20/01 | |
Peter Zippelius
BRD | Director/Board Member | 45 | 01/19/01 |
Director/Board Member | - | - |
Company contact information
Sector
1st Jan change | Capi. | |
---|---|---|
-.--% | 6.07B | |
+1.51% | 42.75B | |
+49.22% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- WCGC Stock
- Company WCG Clinical, Inc.